Mercer Times

BIOQuébec and BioNJ have entered into a Memorandum of Understanding (MOU) to strengthen cooperation between the life sciences sectors in Québec and New Jersey. This agreement was signed during Choose New Jersey’s economic mission in Canada, led by the Governor. The partnership aims to provide members of both organizations with access to new resources, international markets, and events that promote innovation and growth in the biopharma and biotech industries.

Governor Murphy highlighted New Jersey's innovative environment, stating, “New Jersey is the home of innovation with a thriving life sciences sector reaching new heights through collaboration with industry partners abroad.” He emphasized that this partnership is crucial for advancing research, development, education, and patient interests.

The MOU outlines a framework for sharing best practices and promoting bilateral events such as trade missions and joint conferences. It seeks to expand the global reach of life sciences communities in both regions.

Benoit Larose, CEO of BIOQuébec, expressed enthusiasm about the partnership: "We are excited to partner with BioNJ through this Memorandum of Understanding." He noted that strong international relationships are essential for mitigating risks associated with volatile supply chains while creating value for members.

Debbie Hart, President & CEO of BioNJ, remarked on the importance of strategic partnerships: "Alliances like the one between BioNJ and BIOQuébec serve as catalysts for innovation." She stated that these collaborations aim to accelerate medical breakthroughs globally.

Wesley Mathews, President & CEO of Choose New Jersey, commented on facilitating this collaboration: “As New Jersey’s leading business attraction organization, Choose New Jersey is proud to facilitate this powerful collaboration.”

Details about specific events arising from this partnership will be shared with members in upcoming months.